The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design
- PMID: 24552282
- PMCID: PMC3930821
- DOI: 10.1186/1471-244X-14-48
The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design
Abstract
Background: Animal studies have shown that methylphenidate (MPH) and fluoxetine (FLX) have different effects on dopaminergic and serotonergic system in the developing brain compared to the developed brain. The effects of Psychotropic drugs On the Developing brain (ePOD) study is a combination of different approaches to determine whether there are related findings in humans.
Methods/design: Animal studies were carried out to investigate age-related effects of psychotropic drugs and to validate new neuroimaging techniques. In addition, we set up two double-blind placebo controlled clinical trials with MPH in 50 boys (10-12 years) and 50 young men (23-40 years) suffering from ADHD (ePOD-MPH) and with FLX in 40 girls (12-14 years) and 40 young women (23-40 years) suffering from depression and anxiety disorders (ePOD-SSRI). Trial registration numbers are: Nederlands Trial Register NTR3103 and NTR2111. A cross-sectional cohort study on age-related effects of these psychotropic medications in patients who have been treated previously with MPH or FLX (ePOD-Pharmo) is also ongoing. The effects of psychotropic drugs on the developing brain are studied using neuroimaging techniques together with neuropsychological and psychiatric assessments of cognition, behavior and emotion. All assessments take place before, during (only in case of MPH) and after chronic treatment.
Discussion: The combined results of these approaches will provide new insight into the modulating effect of MPH and FLX on brain development.
Figures
References
-
- Swaab DF, Boer K, Swaab DF, Boer K. In: Fetal and Neonatal Neurology and Neurosurgery. 3. Levene MI, Whittle MJ, Chervenak FA, Punt J, Bennett MJ, editor. Churchill Livingstone: Elsevier; 2001. Functional teratogenic effects of chemicals on the developing brain; pp. 251–265.
-
- Karanges E, Li KM, Motbey C, Callaghan PD, Katsifis A, McGregor IS. Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? Int J Neuropsychopharmacol. 2011;14:491–504. doi: 10.1017/S146114571100006X. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical